Home

Pharmacological Index

Active Ingredients

News

Methylphenidate Teva
/ Teva Israel LTD, Israel

Drug summary

CNS Stimulant. Methylphenidate HCl 18/27/36/54 mg.
PR Tabs 30/90 X 18/27/36/54 mg
Ped. pts. 6 to 12 years of age: start 18 mg once/d, range: 18 mg to 54 mg once/d. Pts 13 to 17 years of age: start 18 mg once/d, range: 18 mg to 72 mg once/d (not to exceed 2 mg/kg/d). Adults 18 to 65 years of age: start 18 or 36 mg once/d, range: 18 mg to 72 mg once/d.
Tmt.of Attention Deficit Hyperactivity Disorder (ADHD). in pts aged 6 to 65 years old.
C/I: Hypersens• Anxiety, tension • Agitation • Hyperthyroidism • Pre-existing cardiovasc. dis. incl. sev. hypertens, angina, arterial occlusive dis; HF, haemodynamically signif.congenital heart dis., cardiomyopathies, myocardial infarction, potentially life-threatening arrhythmias and channelopathies (disorders caused by the dysfunction of ion channels) • During tmt. with monoamine oxidase (MAO) inhibitors, or within a min. of 2 weeks of discontinuing those drugs, due to risk of hypertensive crisis • Glaucoma • Phaeochromocytoma • Diagnosis or family hist. of Tourette's syndr.

INFO LINE

Active Ingredient

Methylphenidate HCl 18/27/36/54 mg

Status in Israel

Presentation and Status in Health Basket

Presentation	Basket	Yarpa	Pharmasoft
Prolonged-Release Tablets 30 X 18 mg		28336	15989
Prolonged-Release Tablets 30 X 27 mg		29509	15897
Prolonged-Release Tablets 30 X 36 mg		31155	15896
Prolonged-Release Tablets 30 X 54 mg		29510	15895

Related information

Dosage

Please refer to the license holder for further details.

Indications

Methylphenidate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 to 65 years old

Contra-Indications

Please refer to the license holder for further details.

Special Precautions

Please refer to the license holder for further details.

Side Effects

Please refer to the license holder for further details.

Drug interactions

Please refer to the license holder for further details.

Pregnancy and Lactation

Please refer to the license holder for further details.

Overdose

Please refer to the license holder for further details.

Manufacturer

Teva Israel Ltd

Licence holder

Teva Israel LTD, Israel